Development of a quality of life tool for post-COVID-19 patients
Official title: Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)
Run by Medialis Ltd. · NCT04586413 · Data updated 2026-11-12
This study is trying to create a new tool to measure how COVID-19 affects the quality of life for people recovering from the virus, including those who were hospitalized and those who weren't.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Medialis Ltd. Industry-sponsored |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | October 7, 2020 |
| Main results expected | October 2028 |
| Study ends | October 2028 |
| Registry record updated | October 23, 2023 |
| Trial ID | NCT04586413 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have had a confirmed COVID-19 infection or antibody test.
✕Probably not a fit
Patients who have not been diagnosed with COVID-19 or are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop a specific quality of life measure for individuals recovering from COVID-19. Participants will be recruited and divided into three groups based on their hospitalization status: not hospitalized, hospitalized but not in intensive care, and hospitalized in intensive care. The study will utilize a novel method to gather insights from participants about the areas of their lives affected by COVID-19, which will inform the creation of the quality of life tool. Following the development phase, participants will be invited to complete the tool monthly for a year to assess its effectiveness.
Why it matters
Potential benefit: If successful, this study could provide a tailored quality of life measure that better reflects the experiences of post-COVID-19 patients.
How similar studies have gone: While there have been studies on quality of life in COVID-19 patients, the specific approach of developing a patient-reported measure based on direct input from patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Phase One Inclusion Criteria: * The participant has had either a confirmed COVID-19 test while infected or a confirmed COVID-19 antibody test post-infection * The participant is aged 18 years or older * The participant is capable of providing informed consent * The participant can read, write and converse in English * The participant can comply with the study schedule Exclusion Criteria: * The participant does not have a confirmed COVID-19 test or antibody test * The participant is aged under 18 years * The participant is not capable of giving informed consent * The participant is unable to read, write and converse in English * The participant is unable to comply with study schedule data collection Phase Two Inclusion Criteria: * The participant has had either a confirmed COVID-19 test while infected or a confirmed COVID-19 antibody test post-infection or a clinical diagnosis of COVID-19 * The participant is aged 18 years or older * The participant is capable of providing informed consent * The participant can read, write and converse in English * The participant can comply with the study schedule Exclusion Criteria: * The participant does not have a confirmed COVID-19 test or antibody test or clinical diagnosis of COVID-19 * The participant is aged under 18 years * The participant is not capable of giving informed consent * The participant is unable to read, write and converse in English * The participant is unable to comply with study schedule data collection
Where it's running
-
Medialis
Oxford, United Kingdom Recruiting
Study contacts
- Study coordinator: Omolade Femi-Ajao, PhD
- Email: research@medialis.co.uk
- Phone: +447502228066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating olfactory dysfunction after COVID-19 infection
This study is trying to understand why some people still have trouble smelling after recovering from COVID-19 by looking at samples from their noses.
-
Registry to evaluate pregnancy outcomes in women treated for COVID-19
This study is trying to see how treatments for COVID-19, like certain medications, affect the health of pregnant women and their babies.
-
Collecting COVID-19 virus secretions and serum for developing treatments
This study is collecting samples from people with COVID-19 to learn more about how the virus behaves and how it affects recovery, with the goal of improving treatments for those at higher risk.
-
Using donor-derived T cells to treat mild to moderate COVID-19
This study is testing whether T cells from family members who have recovered from COVID-19 can help treat hospitalized patients with mild to moderate COVID-19.
-
Observational study on the biology of COVID-19 in Saarland
This study looks at how COVID-19 affects people in different ways, including those with long-term symptoms, to learn more about the disease and its progression.
-
Imaging immune activation in COVID-19 patients
This study is testing a special imaging technique to see how the immune system is working in people who have recently recovered from COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.